Adagio Therapeutics, Inc.·4

Jun 24, 4:36 PM ET

Mayer Howard 4

4 · Adagio Therapeutics, Inc. · Filed Jun 24, 2022

Insider Transaction Report

Form 4
Period: 2022-06-22
Mayer Howard
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-22+75,00075,000 total
    Exercise: $3.09Exp: 2032-06-21Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]This option was granted on June 22, 2022 and vests in full on the earlier of (i) June 22, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to continued service through the vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION